Related Experiment Videos
Primary intracranial Hodgkin's lymphoma without dural attachment. Case report
W C Clark1, T Callihan, L Schwartzberg
1Semmes-Murphey Clinic, Department of Neurosurgery, Memphis, Tennessee.
Journal of Neurosurgery
|April 1, 1992
Abstract:
A very rare case of primary intracranial Hodgkin's lymphoma without dural attachment is reported. Based on a review of the literature and the clinical results in the present case, recommended therapy consists of surgical excision whenever possible, followed by radiotherapy.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease.
Alimentary pharmacology & therapeutics·2013
An atypical presentation of lymphangitis carcinomatosis.
BMJ case reports·2026
Harnessing autophagy-dependent ferroptosis: Mechanisms and therapeutic opportunities in human diseases.
Pharmacological research·2026
Functional regulation of midkine (MDK) and its link to cancer.
Cancer genetics·2026